Updated News Around the World
Gland Pharma’s poor show in FY23 has shaken investor confidence. Can it reclaim lost ground?
Technology

Gland Pharma’s poor show in FY23 has shaken investor confidence. Can it reclaim lost ground?

By Andrew McCollum

Gland Pharma’s plant at Pashamylaram, Telangana; image credit: company

Synopsis

Given the consistent disappointments on the earnings front, investors are starting to worry if there is a structural issue with the business. The management has not been transparent in its communication and also did not give any guidance on revenue growth or margins for FY24, citing uncertainties in the business environment. This further dampened investor sentiment.

Gland Pharma has left shareholders exasperated. Earnings have deteriorated significantly in the last few quarters and, consequently, the stock has declined nearly 70% in the past one year. When the Hyderabad-based pure-play generic injectables company had come out with its initial public offering (IPO) in November 2020, it looked quite promising and garnered strong interest from investors. Gland Pharma had listed at a premium of 14% over its

BY

8 mins read, Last Updated:

  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • PRINT
  • COMMENT

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Read this story for free.

Unlock your 30 days free access to ETPrime now.

Login to unlock

*No card details required.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

  • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

For all the latest Technology News Click Here 

 For the latest news and updates, follow us on Google News. 

Read original article here

Denial of responsibility! NewsUpdate is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Andrew McCollum 109721 posts 0 comments